The expression levels of markers were identified as the median fluorescence intensity of gated CTLs. To assess CTL function, CTL-JB4 (3 105) (precultured with APCs) were mixed with cognate tumor cells (HLA-A2+ RCC-26) at a percentage of 1 1:1 in the presence DAPK Substrate Peptide of GolgiStop and Brefeldin-A (BD Biosciences, Franklin Lakes, NJ) in AIM-V with 10% HS. B: (630 magnification) shows a close contact between a T cell and a CD209+ cell. mmc1.pdf (1.6M) GUID:?CD9DDB41-9295-4C8D-BF7B-6D0E504E3C8C Supplemental Number S2 MMP-9 secretion and proliferation of RCC cells induced by human being rTNF- or supernatants of CTL/APC co-cultures. Human being rTNF- induces MMP-9 secretion (A) and proliferation (B) of RCC cells by carcinoma-secreted factors (CXCL8/IL-8, IL-6, and vascular endothelial growth element). ErcDCs resembled standard DCs in costimulatory molecule manifestation and antigen cross-presentation. They did not suppress cognate cytotoxic T-lymphocyte function and did not cause CD3 down-regulation, FOXP3 induction, or T-cell apoptosis or = 8) and two different tumor areas, the tumor center (= 11) and the tumor periphery (= 6). Cells representing the three cells areas were selected macroscopically. NKC cells were derived from areas with the longest possible distance away from any tumor region. Histologic sections were microscopically free of malignant cells. Histologic sections of the tumor periphery were cross-sectional cuts that microscopically encompassed nontumor kidney, the pseudocapsule that surrounds the tumor, separating it from your nontumor kidney area, and the tumor region (observe Supplemental Number S1A at Generation of Myeloid Cell Subtypes Monocytes were isolated from peripheral blood mononuclear cells using CD14+ microbeads (Miltenyi) and cultivated serum free (5 106/4 mL of AIM-V) with IL-4 (400 U/mL; CellGenix, Freiburg, Germany) and granulocyte-macrophage colony-stimulating element (GM-CSF/Leukine; 800 U/mL; Genzyme, Cambridge, MA) to DAPK Substrate Peptide generate CD209 single-positive standard DCs (cDCs). For tissue-conditioned cells, monocytes were cultivated with 20% cell-conditioned press or with CXCL8/IL-8 (7 ng/mL; PeproTech, Rocky Hill, NJ), IL-6 (1.9 ng/mL), and vascular endothelial growth factor (VEGF) (23.4 ng/mL) (both R&D Systems, Minneapolis, MN) or in mixtures. The concentrations reflected those of RCC-26Cconditioned medium. Functional analyses were performed with monocytes generated with RCC-26Cconditioned medium. Myeloid cells within one experiment were derived from the same donor. Generation of Microtumors and Monocyte Infiltration Multicellular spheroids were generated as previously explained.28 In brief, 105 suspended cells from exponentially growing RCC-53 monolayers were cultured on 1% stable seaplaque agarose (Biozym, Wien, Austria) in 24-well plates. After 4 days, the limited aggregates were transferred to 20 L of AIM-V comprising 105 monocytes and cultured as hanging drops within the TBLR1 lid of a petri dish. After 24 hours, noninfiltrated monocytes were removed and the spheroids cultured for 3 more days. Thereafter, spheroids were dispersed in 5 mmol/L EDTA (mechanic disruption) and the single-cell suspension was analyzed by circulation cytometry using LSRII (gated on CD45+ cells) (BD Pharmingen, San Diego, CA) and FlowJo (TreeStar, Ashlan, OR). Macropinocytosis, Endocytosis, and Phagocytosis For macropinocytosis, cells (3 105 cells/600 L) were incubated with fluorescein isothiocyanate (FITC)Clabeled BSA (1 mg/mL; Sigma-Aldrich) for 1 hour at 37C or 4C (control) and analyzed by circulation cytometry. Endocytosis involved FITC-labeled dextran (500 kDa; Sigma-Aldrich). For phagocytosis, the Vybrant phagocytosis assay (Molecular Probes/Invitrogen) was used. Antigen Cross-Presentation Antigen cross-presentation was performed as previously explained. 29 The system entails the HLA-A2Crestricted Melan-A/MART-1Cspecific CTL-A42 and the pep70-MART peptide, which is an prolonged 15mer peptide comprising the HLA-A2Crestricted T-cell epitope of the Melan-A/MART-1 antigen. The N-terminal extension prevents direct loading onto surface HLA-A2 molecules; therefore, epitope demonstration requires antigen uptake DAPK Substrate Peptide and control by antigen-presenting cells (APCs) to accomplish T-cell activation. T-cell stimulation results in interferon- (IFN-) secretion, which correlates with the amount of antigen cross-presented from the APCs.29 Myeloid cells (2 104/100 L of AIM-V) were incubated with indicated concentrations of pep70-MART peptide for 1 hour at 37C to allow uptake before addition of resting CTL-A42 (4 103/100 L of AIM-V, 24 hours, 37C). IFN- in supernatants was measured by enzyme-linked.